{"title":"Duration and determinants of biologic initiation in the treatment of severe asthma","authors":"Tatsuya Imabayashi , Toshiyuki Tanaka , Kohei Yamamoto , Kazuki Jinno , Shunya Tanaka , Sayaka Uda , Tatsuya Yuba , Chieko Takumi","doi":"10.1016/j.resinv.2025.06.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Factors influencing biologic initiation in severe asthma remain unclear.</div></div><div><h3>Methods</h3><div>We retrospectively evaluated the duration and determinants of biologic initiation in 54 patients with severe asthma who were started on biologics at our hospital between 2018 and 2024.</div></div><div><h3>Results</h3><div>The median age was 74 years, and 72.2 % of the patients were biologic-naïve. Patients required a median of three explanations for biologic initiation, with 25.9 % requiring four or more. These patients had a higher prevalence of pre-prescribed oral corticosteroids (OCS) for anticipated exacerbations (58.3 % vs. 7.1 %, P < 0.001) and more frequent exacerbations (median, 4 vs. 1; P = 0.004). Multivariate analysis identified pre-prescribed OCS as an independent factor requiring four or more explanations (adjusted odds ratio, 10.50; P = 0.008). Exacerbation was the primary determinant of initiation (64.8 %).</div></div><div><h3>Conclusions</h3><div>Pre-prescribed OCS and frequent exacerbations contributed to delays in biologic initiation. To facilitate timely initiation, habitual pre-prescribed OCS use without an action plan should be avoided.</div></div>","PeriodicalId":20934,"journal":{"name":"Respiratory investigation","volume":"63 5","pages":"Pages 718-722"},"PeriodicalIF":2.4000,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory investigation","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212534525000838","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Factors influencing biologic initiation in severe asthma remain unclear.
Methods
We retrospectively evaluated the duration and determinants of biologic initiation in 54 patients with severe asthma who were started on biologics at our hospital between 2018 and 2024.
Results
The median age was 74 years, and 72.2 % of the patients were biologic-naïve. Patients required a median of three explanations for biologic initiation, with 25.9 % requiring four or more. These patients had a higher prevalence of pre-prescribed oral corticosteroids (OCS) for anticipated exacerbations (58.3 % vs. 7.1 %, P < 0.001) and more frequent exacerbations (median, 4 vs. 1; P = 0.004). Multivariate analysis identified pre-prescribed OCS as an independent factor requiring four or more explanations (adjusted odds ratio, 10.50; P = 0.008). Exacerbation was the primary determinant of initiation (64.8 %).
Conclusions
Pre-prescribed OCS and frequent exacerbations contributed to delays in biologic initiation. To facilitate timely initiation, habitual pre-prescribed OCS use without an action plan should be avoided.
影响严重哮喘生物起始的因素尚不清楚。方法回顾性评估2018年至2024年在我院开始使用生物制剂的54例重症哮喘患者的生物起始时间和决定因素。结果中位年龄为74岁,72.2%的患者年龄为biologic-naïve。患者对生物起源的解释中位数为三种,其中25.9%需要四种或更多。这些患者在预期加重时使用处方口服皮质类固醇(OCS)的患病率较高(58.3% vs. 7.1%, P <;0.001)和更频繁的恶化(中位数,4比1;p = 0.004)。多变量分析发现,处方OCS是需要四种或更多解释的独立因素(调整优势比,10.50;p = 0.008)。病情恶化是发病的主要决定因素(64.8%)。结论预先处方的OCS和频繁的加重导致生物起始延迟。为了方便及时启动,应避免在没有行动计划的情况下习惯性地使用预先规定的OCS。